Mittie Doyle

Insider Reports History

Location
C/O Dice Therapeutics, Inc., 279 E. Grand Avenue, Suite 300, Lobby B, South San Francisco, CA
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mittie Doyle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avalo Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 155K Jan 28, 2025 Direct
Cullinan Therapeutics, Inc. Director Stock Option (Right to Buy) 79.5K Aug 7, 2025 Direct
DICE Therapeutics, Inc. Director Stock Option (right to buy) 0 Aug 9, 2023 Direct

Insider Reports Filed by Mittie Doyle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGEM Cullinan Therapeutics, Inc. Aug 7, 2025 1 $0 4 Aug 8, 2025 Director
CGEM Cullinan Therapeutics, Inc. Aug 7, 2025 0 $0 3 Aug 8, 2025 Director
AVTX Avalo Therapeutics, Inc. Jan 28, 2025 1 $0 4 Jan 30, 2025 Chief Medical Officer
AVTX Avalo Therapeutics, Inc. Jul 15, 2024 1 $0 4 Jul 16, 2024 Chief Medical Officer
AVTX Avalo Therapeutics, Inc. Jul 15, 2024 0 $0 3 Jul 16, 2024 Chief Medical Officer
DICE DICE Therapeutics, Inc. Aug 9, 2023 1 $0 4 Aug 9, 2023 Director
DICE DICE Therapeutics, Inc. Mar 31, 2022 1 $0 4 Apr 1, 2022 Director
DICE DICE Therapeutics, Inc. Mar 24, 2022 0 $0 3 Apr 1, 2022 Director